{"version":"1.0","provider_name":"Clario","provider_url":"https:\/\/clario.com","author_name":"Gary Norman","author_url":"https:\/\/clario.com\/author\/garyn\/","title":"Every Patient Matters: Bespoke Digital Endpoint Strategies for Rare Disease Drug Development Webinar Replay","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"dX0JV8kNny\"><a href=\"https:\/\/clario.com\/resources\/webinars\/every-patient-matters-bespoke-digital-endpoint-strategies-for-rare-disease-drug-development-webinar-replay\/\">Every Patient Matters: Bespoke Digital Endpoint Strategies for Rare Disease Drug Development Webinar Replay<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/clario.com\/resources\/webinars\/every-patient-matters-bespoke-digital-endpoint-strategies-for-rare-disease-drug-development-webinar-replay\/embed\/#?secret=dX0JV8kNny\" width=\"600\" height=\"338\" title=\"&#8220;Every Patient Matters: Bespoke Digital Endpoint Strategies for Rare Disease Drug Development Webinar Replay&#8221; &#8212; Clario\" data-secret=\"dX0JV8kNny\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/clario.com\/wp-content\/uploads\/2021\/11\/Clario-Website-Open-Graph-Image.jpg","thumbnail_width":1200,"thumbnail_height":627,"description":"Rare disease drug development presents unique challenges: patient populations are often minimal, clinical endpoints may not be well-established and traditional approaches to evidence generation cannot always be applied. To succeed, sponsors need flexible, carefully tailored digital endpoint strategies that can adapt to the realities of rare disease trials. In this webinar, the featured speakers illustrate"}